Top Wall Street Forecasters Revamp Micron Expectations Ahead Of Q4 Earnings

Micron Technology (MU) is scheduled to release its Q4 earnings on September 23rd, with analysts anticipating strong year-over-year growth to $2.86 EPS and $11.11 billion in revenue, following a Q3 period where sales beat estimates despite an EPS miss. This upcoming report is preceded by several prominent analysts, including Susquehanna, Wolfe Research, and UBS, recently maintaining positive ratings and raising their price targets for MU, signaling robust institutional confidence in the semiconductor firm's outlook. Micron shares closed up 0.7% at $159.99, reflecting market anticipation.

Analysis

Micron Technology (MU) is positioned for a significant market event with its upcoming fourth-quarter earnings release, where analysts are forecasting substantial growth. The consensus estimate projects quarterly earnings per share to more than double year-over-year to $2.86, with revenue expected to climb to $11.11 billion from $7.75 billion a year earlier. This optimistic outlook follows a mixed third quarter, where the company's sales of $4.46 billion (+5.4% YoY) surpassed expectations, but its reported earnings per share missed the consensus estimate. Reinforcing the bullish sentiment ahead of the report, five prominent and high-accuracy analysts from firms including Susquehanna, Wolfe Research, and UBS have recently reiterated positive ratings and uniformly raised their price targets. These new targets, which range from $175 to $200, are all considerably above the stock's recent closing price of $159.99, indicating strong institutional conviction in the company's near-term and future performance.

Key Decisions for Investors

• Investors should prepare for significant volatility around the earnings announcement, as the stock's performance will be highly sensitive to whether the company meets or exceeds the elevated consensus expectations for both revenue and EPS.
• The forward-looking guidance provided by management during the earnings call will be the most critical data point, as it must validate the bullish thesis underpinning the recent wave of analyst price target increases to the $175-$200 range.
• Given the stock is trading below all recently revised analyst price targets, a long position may be considered, but it requires acknowledging the execution risk and the potential for a pullback if results or guidance disappoint.